Cleared Traditional

K010024 - O2/CO2 NASAL FILTERLINE

K010024 is the FDA 510(k) clearance for O2/CO2 NASAL FILTERLINE by Oridion Medical 1987 , Ltd.. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 70-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2001
Decision
70d
Days
Class 2
Risk

K010024 is an FDA 510(k) clearance for the O2/CO2 NASAL FILTERLINE. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical 1987 , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on March 14, 2001 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oridion Medical 1987 , Ltd. devices

Submission Details

510(k) Number K010024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 2001
Decision Date March 14, 2001
Days to Decision 70 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 140d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 124
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K010024.
DATEX-OHMEDA S/5 SINGLE-WIDTH AIRWAY MODULE M-MINIC AND ACCESSORIES
K023454 · Datex-Ohmeda · Apr 2003
MULTIGAS UNIT, MODEL AG-920RA
K020046 · Nihon Kohden America, Inc. · Jul 2002
VAMOS ANESTHETIC GAS MONITOR
K012139 · Draeger Medical, Inc. · Jan 2002
INFINITY ETCO2 + RESPIRATORY MECHANICS POD
K003550 · Siemens Medical Solutions USA, Inc. · Mar 2001
DATEX-OHMEDA COMPACT AIRWAY MODULE M-CAIOVX AND M-COVX (VERSION 01) AND ACCESSORIES
K001814 · Datex-Ohmeda · Aug 2000
DATEX-OHMEDA TONOMETRY MODULE M-TONO
K993656 · Datex-Ohmeda, Inc. · Mar 2000